Hess shareholders approve merger with Chevron-March 2024-www.financetom.com

Hess shareholders approve merger with Chevron

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Hess shareholders approve merger with Chevron

May 28, 2024 11:38 AM

HOUSTON, May 28 (Reuters) - Hess Corp ( HES ) on Tuesday

approved the company's $53 billion merger with the No. 2 U.S.

oil company Chevron ( CVX ), according to preliminary results of the

vote.

The merger required a majority of Hess' 308 million shares

outstanding to pass. The company did not immediately provide the

vote tally.

Previous page： Li Auto Reports Higher Deliveries for March, Q1 Next page： Update: Nutex Health Shares Soar Pre-Bell Following Return to Profit in Q4 as Revenue Surges

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Li Auto Reports Higher Deliveries for March, Q1

Apr 1, 2025

05:00 AM EDT, 04/01/2025 (MT Newswires) -- Li Auto ( LI ) said Tuesday it delivered 36,674 vehicles in March, up nearly 27% from a year earlier. The company's Q1 deliveries rose 16% year over year to 92,864. Li Auto ( LI ) shares were up 1% in recent premarket activity. ...

Update: Nutex Health Shares Soar Pre-Bell Following Return to Profit in Q4 as Revenue Surges

Apr 1, 2025

04:40 AM EDT, 04/01/2025 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Nutex Health ( NUTX ) shares were up more than 42% in premarket activity Tuesday after the company reported overnight a swing back into the black as sales more than tripled in Q4. The company reported Q4 diluted earnings of $11.12...

Sneaker maker On co-CEO to depart

Apr 1, 2025

April 1 (Reuters) - Roger Federer-backed On Holding said on Tuesday its co-CEO Marc Maurer has decided to depart the sportswear company. ...

Lilly sues two compounders over copies of weight-loss drugs

Apr 1, 2025

April 1 (Reuters) - Eli Lilly ( LLY ) said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ingredient in its popular weight-loss and diabetes medicines. This comes after a U.S. federal judge last month refused to allow compounding pharmacies to keep making copies of these drugs in the United States....